Ionis Pharmaceuticals: Fourth Quarter Earnings Overview

Ionis Pharmaceuticals Reports Fourth Quarter Financial Results

Ionis Pharmaceuticals Inc., headquartered in Carlsbad, California, announced a net loss of $229 million for the fourth quarter.

The company reported a quarterly loss of $1.41 per share, which narrows to $1.14 per share when excluding stock option expenses.

During this period, Ionis generated $203 million in revenue, exceeding analyst expectations. According to a survey by Zacks, seven analysts had projected revenue of $155.6 million.

For the entire year, Ionis recorded a total loss of $381 million, or $2.38 per share, with annual revenue reaching $944 million.

Looking ahead, the company anticipates its revenue for the upcoming year will fall between $800 million and $825 million.